H. Eric Cannon, PharmD, FAMCP

Articles by H. Eric Cannon, PharmD, FAMCP

Considerations for Optimal Management of Patients With Pulmonary Arterial Hypertension: A Multi-Stakeholder Roundtable Discussion

BySean M. Studer, MD, MSc,Martha Kingman, FNP-C,DNP,Luis Calo, MD, MMM, FAAFP,H. Eric Cannon, PharmD, FAMCP,Jeffrey D. Dunn, PharmD, MBA,Thomas James III, MD,Sonya J. Lewis, PharmD, MBA,Robert J

Stakeholders, including national and regional managed care decision makers and providers, met to discuss the clinical background, health economics, and management strategies for pulmonary arterial hypertension (PAH) at a roundtable meeting on December 10, 2016, in Dallas, Texas.

Latest Updated Articles



Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text